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A Novel Heterozygous ANO3 Mutation 
with Basal Ganglia Dysfunction in a Patient 
with Adult-Onset Isolated Segmental Dystonia
Dear Editor, 
Mutations of ANO3 have recently been found to cause isolated dystonia (DYT24, MIM 
615034),1 predominantly involving the craniocervical area, with the age at onset ranging from 
childhood to the sixth decade of life.2,3 This report describes a Korean patient with segmental 
dystonia caused by a novel variant c.860G>A (p.Arg287Gln) in ANO3 (NM_031418.3 and 
NP_113606.2), with brain PET showing basal ganglia (BG) dysfunction. 
A 60-year-old left-handed woman presented with abnormal posture in her left arm and 
the neck that had first appeared 6 years previously. She had not taken any medication that 
can cause dystonia, and there was no family history of tremor or dystonia (Fig. 1A). A neu-
rological examination showed an abnormal posture with slow and large-amplitude jerky 
tremors in her left arm. She also exhibited mild left torticollis combined with retrocollis arm 
(Supplementary Video 1 in the online-only Data Supplement). Brain MRI produced normal 
findings. Brain 18F-fluorodeoxyglucose (18F-FDG) PET showed increased uptake in the right 
putamen, with decreased uptake in the right subthalamic nucleus (STN) (Fig. 1B). Next-gen-
eration sequencing using a targeted panel of 93 genes for dystonia identified a novel hetero-
zygous missense variant (a G to A substitution at position 860 of ANO3; transcript ID: 
ENST00000256737) that resulted in the replacement of an arginine residue by a glutamine 
residue at position 287 of the anoctamin 3 protein (p.Arg287Gln). This variant was con-
firmed by Sanger sequencing (Fig. 1C). The arginine residue at codon 276 is in the cytoplas-
mic domain of ANO3, which is highly conserved throughout evolution (Fig. 1D). The in silico 
prediction algorithms UMD-Predictor (http://umd-predictor.eu/) and MutationTaster2 
(http://www.mutationtaster.org/) predicted that this missense mutation was pathogenic and 
disease-causing, respectively. The Combined Annotation-Dependent Depletion tool (CADD, 
version 1.3; http://cadd.gs.washington.edu/) produced a score of 34.0. No mutations were de-
tected in other genes known to cause dystonia.
The guidelines of the American College of Medical Genetics and Genomics classify 
p.Arg287Gln of ANO3 as a variant of uncertain significance. The ANO3 variant in the present 
patient is possibly causative for DYT24 for the following reasons: First, the patient presented 
with segmental dystonia similar to findings in previous published dystonia cases with ANO3 
mutations (Supplementary Table 1 in the online-only Data Supplement). Second, in silico 
analyses of this novel variant have predicted that this mutation is pathogenic. To date, 17 
missense mutations and 1 in-frame insertion mutation in ANO3 have been reported as pos-
sible variants causing DYT24 (Supplementary Table 1 in the online-only Data Supplement). 
The CADD score of p.Arg276Gln is equal to the highest score of previously reported muta-
tions. Third, this mutation has not been reported in patients with dystonia or in large public 
databases such as gnomAD, ExAC, and 1,000 Genomes Project.
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18F-FDG-PET assessments of patients with hereditary dys-
tonia have shown changes (increases or decreases) in glucose 
metabolism in the BG, cortices, and cerebellum.4 The altered 
glucose metabolism in the right putamen and STN in the pres-
ent patient may reflect changes within the BG motor circuit. 
ANO3 encodes a calcium (Ca2+)-activated chloride channel 
that is highly expressed in the striatum, especially in the puta-
men, and is thought to play a role in modulating neuronal ex-
citability.1 If abnormal calcium homeostasis is a disease mech-
anism in dystonia,5 then abnormal glucose metabolism in the 
BG of the present patient may explain the pathophysiological 
mechanisms underlying the development of dystonia in pa-
tients with ANO3 mutations.1 We did not detect any abnor-
mality of glucose metabolism in the cortices and cerebellum 
in the present patient, because the 18F-FDG uptake was sym-
metrical in those regions. Additional studies using group com-
parisons such as network analysis are needed to confirm the 
exact topography of metabolic abnormalities revealed by 18F-
FDG-PET in this type of dystonia. 
We have described a Korean patient with segmental dysto-
nia who had a novel ANO3 variant (c.860G>A) and abnormal 
glucose metabolism in the BG.  
Supplementary Video Legend 
Video 1. The patient shows dystonic posture with dystonic 
tremor in the left arm when the arms were stretched and the 
elbows were flexed. She also shows mild torticollis and retro-
collis to the left side in the neck.
Supplementary Materials
The online-only Data Supplement is available with this arti-
cle at https://doi.org/10.3988/jcn.2018.14.4.596.
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Fig. 1. Family pedigree. A: Arrow indicates the proband. B: 18F-flaorodeoxyglucose PET analysis. arrow in the left panel indicates increased metabolism 
in the right striatum. Arrow in the right panel indicates decreased metabolism in the right subthalamus. C: Sanger sequencing confirmation of ANO3 
mutation. D: Complete evolutionary conservation of arginine 287.
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